ZA200706168B - Ibandronate polymorph A - Google Patents

Ibandronate polymorph A

Info

Publication number
ZA200706168B
ZA200706168B ZA200706168A ZA200706168A ZA200706168B ZA 200706168 B ZA200706168 B ZA 200706168B ZA 200706168 A ZA200706168 A ZA 200706168A ZA 200706168 A ZA200706168 A ZA 200706168A ZA 200706168 B ZA200706168 B ZA 200706168B
Authority
ZA
South Africa
Prior art keywords
ibandronate polymorph
ibandronate
polymorph
Prior art date
Application number
ZA200706168A
Other languages
English (en)
Inventor
Eiermann Uwe
Knipp Bernhard
Junghans Bernd
Sattelkau Tim
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36090730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200706168(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200706168B publication Critical patent/ZA200706168B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200706168A 2005-02-01 2007-07-25 Ibandronate polymorph A ZA200706168B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05100686 2005-02-01

Publications (1)

Publication Number Publication Date
ZA200706168B true ZA200706168B (en) 2008-09-25

Family

ID=36090730

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200706168A ZA200706168B (en) 2005-02-01 2007-07-25 Ibandronate polymorph A

Country Status (25)

Country Link
US (1) US7714158B2 (xx)
EP (2) EP2662380B1 (xx)
JP (2) JP5828608B2 (xx)
KR (1) KR100908529B1 (xx)
CN (1) CN101111504B (xx)
AR (1) AR053012A1 (xx)
AU (1) AU2006210009B2 (xx)
BR (1) BRPI0607092A2 (xx)
CA (1) CA2594802C (xx)
CY (1) CY1121703T1 (xx)
DK (1) DK2662380T3 (xx)
ES (2) ES2478302T3 (xx)
HU (1) HUE042316T2 (xx)
IL (1) IL184562A (xx)
LT (1) LT2662380T (xx)
MX (1) MX2007009107A (xx)
NO (1) NO20073723L (xx)
PL (1) PL2662380T3 (xx)
PT (1) PT2662380T (xx)
RU (1) RU2368617C2 (xx)
SI (1) SI2662380T1 (xx)
TR (1) TR201902609T4 (xx)
TW (1) TWI374889B (xx)
WO (1) WO2006081963A1 (xx)
ZA (1) ZA200706168B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1713489E (pt) 2004-08-23 2011-03-03 Teva Pharma Forma cristalina de ibandronato de sódio e processos para a sua preparação
SI1848727T1 (sl) * 2005-02-01 2015-09-30 F. Hoffmann-La Roche Ag Polimorf b ibandronata
WO2007074475A2 (en) * 2005-12-27 2007-07-05 Natco Pharma Limited Novel polymorphic forms of ibandronate
CA2656053A1 (en) * 2006-07-03 2008-01-10 Generics [Uk] Limited Novel process for the preparation of bisphosphonic acids
EP2009016A3 (en) * 2006-11-16 2009-02-25 Teva Pharmaceutical Industries Ltd Process for preparing crystalline form of ibandronate sodium
CA2570949A1 (en) * 2006-12-12 2008-06-12 Apotex Pharmachem Inc. Ibandronate sodium propylene glycol solvate and processes for the preparation thereof
PL2144919T3 (pl) * 2007-04-11 2016-05-31 Hoffmann La Roche Wieloetapowa synteza ibandronianu
KR20100014728A (ko) 2007-04-19 2010-02-10 닥터 레디스 레보러터리즈 리미티드 이반드로네이트 나트륨 다형태
WO2009020483A1 (en) * 2007-08-09 2009-02-12 Teva Pharmaceutical Industries Ltd. Crystalline forms of ibandronate sodium
EP2128166A1 (en) 2008-05-20 2009-12-02 Chemo Ibérica, S.A. Polymorphic forms of Ibandronate sodium and processes for preparation thereof
EP2180003A1 (en) 2008-10-21 2010-04-28 Zentiva, k.s. Preparation of ibandronate trisodium
EP2609101B1 (en) 2010-07-14 2015-01-28 Pharmathen S.A. Process for the preparation of 3-(n-methyl-n-pentyl)amino-1-hydroxypropane-1,1-diphosphonic acid salt or derivatives thereof
TR201200588A2 (tr) 2012-01-18 2012-07-23 Koçak Farma İlaç Ve Ki̇mya Sanayi̇ Anoni̇m Şi̇rketi̇ Sodyum ibandronat monohidrat polimorflarini ve polimorflu karışımlarını hazırlamak için prosesler.
KR20200085441A (ko) 2019-01-07 2020-07-15 엠에프씨 주식회사 이반드로네이트의 신규한 결정형 및 이의 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
TW198039B (xx) * 1988-11-28 1993-01-11 Ciba Geigy Ag
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
DE69907495T2 (de) 1998-10-16 2004-05-06 Akzo Nobel N.V. (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on als reine verbindung
ATE303153T1 (de) * 1998-12-04 2005-09-15 Roche Diagnostics Gmbh Ibandroinsäure zur förderung der osseointegration der endoprothesen
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
CN1404836A (zh) * 2001-09-14 2003-03-26 中生北方生物工程开发研究所 埃本膦酸钠作为预防和治疗骨质疏松症的药物的有效成分的应用
BR0308901A (pt) * 2002-05-10 2005-01-04 Hoffmann La Roche ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose
SI1596870T2 (sl) * 2002-12-20 2011-07-29 Hoffmann La Roche Formulacija z visokim odmerkom ibandronata
WO2006002348A2 (en) 2004-06-23 2006-01-05 Teva Pharmaceutical Industies Ltd. Solid and crystalline ibandronic acid
PT1713489E (pt) 2004-08-23 2011-03-03 Teva Pharma Forma cristalina de ibandronato de sódio e processos para a sua preparação

Also Published As

Publication number Publication date
SI2662380T1 (sl) 2019-04-30
IL184562A0 (en) 2007-10-31
JP5828608B2 (ja) 2015-12-09
DK2662380T3 (en) 2019-03-18
RU2368617C2 (ru) 2009-09-27
CN101111504B (zh) 2011-12-21
NO20073723L (no) 2007-08-28
JP6039754B2 (ja) 2016-12-07
JP2015205907A (ja) 2015-11-19
WO2006081963A1 (en) 2006-08-10
RU2007132701A (ru) 2009-03-10
PT2662380T (pt) 2019-02-27
ES2478302T3 (es) 2014-07-21
TR201902609T4 (tr) 2019-03-21
PL2662380T3 (pl) 2019-05-31
KR20070100394A (ko) 2007-10-10
AU2006210009A1 (en) 2006-08-10
US7714158B2 (en) 2010-05-11
US20060172975A1 (en) 2006-08-03
JP2008529980A (ja) 2008-08-07
CN101111504A (zh) 2008-01-23
AR053012A1 (es) 2007-04-18
EP2662380A1 (en) 2013-11-13
EP1848728B1 (en) 2014-06-11
AU2006210009B2 (en) 2009-08-13
EP1848728A1 (en) 2007-10-31
TWI374889B (en) 2012-10-21
EP2662380B1 (en) 2018-11-21
BRPI0607092A2 (pt) 2009-08-04
TW200638939A (en) 2006-11-16
CA2594802A1 (en) 2006-08-10
CY1121703T1 (el) 2020-07-31
MX2007009107A (es) 2007-09-11
LT2662380T (lt) 2019-03-12
KR100908529B1 (ko) 2009-07-20
ES2712644T3 (es) 2019-05-14
HUE042316T2 (hu) 2019-06-28
IL184562A (en) 2015-11-30
CA2594802C (en) 2012-11-27

Similar Documents

Publication Publication Date Title
ZA200706168B (en) Ibandronate polymorph A
DK3165539T3 (en) Il-17-receptor a antigenbindende proteiner
IL184720A0 (en) Ibandronate polymorph b
AU310896S (en) A carrying case
AU307950S (en) A breathalyser
GB0601150D0 (en) A sprocket
IL190552A0 (en) A peptide-immunoglobulin-conjugate
PL2020847T3 (pl) Kubek udojowy
GB2426998B (en) A letterplate
GB0612084D0 (en) A case
GB2440449B (en) A soakaway
GB0514685D0 (en) A ntineoplastic compounds
GB2441143B (en) A keep assembly
GB0603069D0 (en) A brcklaying aid
GB0617794D0 (en) A nemometer
GB2432617B (en) A gasket
GB0620900D0 (en) A scope
AU308454S (en) A bandalero
GB0614851D0 (en) A soakaway
GB0617217D0 (en) A soakaway
AU311722S (en) A range
AU302744S (en) A powerboard
GB0520052D0 (en) A rainpal
AU302745S (en) A powerboard
GB0515818D0 (en) A novel compound